1. Home
  2. ASRT vs DOMH Comparison

ASRT vs DOMH Comparison

Compare ASRT & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • DOMH
  • Stock Information
  • Founded
  • ASRT 1995
  • DOMH 1967
  • Country
  • ASRT United States
  • DOMH United States
  • Employees
  • ASRT N/A
  • DOMH N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASRT Health Care
  • DOMH Health Care
  • Exchange
  • ASRT Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • ASRT 57.9M
  • DOMH 68.4M
  • IPO Year
  • ASRT 1997
  • DOMH N/A
  • Fundamental
  • Price
  • ASRT $0.61
  • DOMH $5.99
  • Analyst Decision
  • ASRT Strong Buy
  • DOMH
  • Analyst Count
  • ASRT 3
  • DOMH 0
  • Target Price
  • ASRT $3.08
  • DOMH N/A
  • AVG Volume (30 Days)
  • ASRT 305.8K
  • DOMH 204.6K
  • Earning Date
  • ASRT 05-12-2025
  • DOMH 05-20-2025
  • Dividend Yield
  • ASRT N/A
  • DOMH 5.37%
  • EPS Growth
  • ASRT N/A
  • DOMH N/A
  • EPS
  • ASRT N/A
  • DOMH N/A
  • Revenue
  • ASRT $124,961,000.00
  • DOMH $18,146,000.00
  • Revenue This Year
  • ASRT N/A
  • DOMH N/A
  • Revenue Next Year
  • ASRT $11.20
  • DOMH N/A
  • P/E Ratio
  • ASRT N/A
  • DOMH N/A
  • Revenue Growth
  • ASRT N/A
  • DOMH 789.95
  • 52 Week Low
  • ASRT $0.51
  • DOMH $0.83
  • 52 Week High
  • ASRT $1.80
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 43.47
  • DOMH 63.75
  • Support Level
  • ASRT $0.58
  • DOMH $4.40
  • Resistance Level
  • ASRT $0.66
  • DOMH $5.72
  • Average True Range (ATR)
  • ASRT 0.05
  • DOMH 0.48
  • MACD
  • ASRT 0.00
  • DOMH 0.17
  • Stochastic Oscillator
  • ASRT 23.53
  • DOMH 88.24

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

Share on Social Networks: